A multicenter, prospective epidemiologig study of the progression of geographic atropy secondary to age-related magular degeneration

A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lamipalizumab administered intravitreally to patients with geographic atrophy secondary to age-related miacular degeneration

A prospective, open-label, multicenter, randomized phase III trial to compare the efficacy and safety of a combined regimen of obinutuzumab and GDC-0199 (ABT-199) versus obinutuzumab and chlorambucil in previously untreated patients with CLL and coexisting medical conditions

Eine offene, multizentrische, randomisisierte Studie der Phase III zur Untersuchung der Wirk-samkeit und Sicherheit von MPDL3280A (anti-PD-L1 Antikörper) im Vergleich mit Chemothe-rapie bei Patienten mit lokal fortgeschrittenem oder metastasiertem Urothelkarzinom der Harn-blase nach Versagen einer platinhaltigen Chemotherapie

Forum 2015 – Epithliale Hauttumore - eine interdisziplinäre Herausforderung

Onko-Patho-Workshop

Symposium 2015 – 9. Jahressymposium INDIRA

Toffife – Tocilizumab for the Treatment of Familial Mediterranean Fever

Trilogy – A PHASE III, DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB PLUS COBIMETINIB AND VEMURAFENIB VERSUS PLACEBO PLUS COBIMETINIB AND VEMURAFENIB IN PREVIOUSLY UNTREATED BRAFV600 MUTATION−POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMA